Logo image of GNUS

Genius Brands International Inc (GNUS) Stock Fundamental Analysis

NASDAQ:GNUS - Nasdaq - US37229T5092 - Common Stock - Currency: USD

3.24  +0.25 (+8.36%)

After market: 3.23 -0.01 (-0.31%)

Fundamental Rating

1

Taking everything into account, GNUS scores 1 out of 10 in our fundamental rating. GNUS was compared to 71 industry peers in the Entertainment industry. GNUS has a bad profitability rating. Also its financial health evaluation is rather negative. GNUS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year GNUS has reported negative net income.
In the past year GNUS has reported a negative cash flow from operations.
GNUS had negative earnings in each of the past 5 years.
In the past 5 years GNUS always reported negative operating cash flow.
GNUS Yearly Net Income VS EBIT VS OCF VS FCFGNUS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -100M -200M -300M -400M

1.2 Ratios

GNUS has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GNUS Yearly ROA, ROE, ROICGNUS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -100 -200 -300

1.3 Margins

Looking at the Gross Margin, with a value of 19.65%, GNUS is doing worse than 70.67% of the companies in the same industry.
GNUS's Gross Margin has been stable in the last couple of years.
GNUS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y0.53%
GNUS Yearly Profit, Operating, Gross MarginsGNUS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -5K -10K -15K

More info and screens

2

2. Health

2.1 Basic Checks

GNUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
GNUS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for GNUS is higher compared to a year ago.
GNUS Yearly Shares OutstandingGNUS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M 250M
GNUS Yearly Total Debt VS Total AssetsGNUS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M 200M

2.2 Solvency

GNUS has an Altman-Z score of -4.09. This is a bad value and indicates that GNUS is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of GNUS (-4.09) is worse than 80.00% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that GNUS is not too dependend on debt financing.
GNUS has a Debt to Equity ratio of 0.02. This is in the better half of the industry: GNUS outperforms 70.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -4.09
ROIC/WACCN/A
WACC7.88%
GNUS Yearly LT Debt VS Equity VS FCFGNUS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.26 indicates that GNUS should not have too much problems paying its short term obligations.
GNUS has a Current ratio (1.26) which is in line with its industry peers.
GNUS has a Quick Ratio of 1.26. This is a normal value and indicates that GNUS is financially healthy and should not expect problems in meeting its short term obligations.
GNUS has a Quick ratio (1.26) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
GNUS Yearly Current Assets VS Current LiabilitesGNUS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for GNUS have decreased strongly by -30.34% in the last year.
GNUS shows a strong growth in Revenue. In the last year, the Revenue has grown by 809.71%.
The Revenue has been growing by 63.45% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-30.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-419.17%
Revenue 1Y (TTM)809.71%
Revenue growth 3Y119.26%
Revenue growth 5Y63.45%
Sales Q2Q%884.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GNUS Yearly Revenue VS EstimatesGNUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
GNUS Yearly EPS VS EstimatesGNUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5 -10 -15

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GNUS. In the last year negative earnings were reported.
Also next year GNUS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNUS Price Earnings VS Forward Price EarningsGNUS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNUS Per share dataGNUS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GNUS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Genius Brands International Inc

NASDAQ:GNUS (6/23/2023, 8:00:02 PM)

After market: 3.23 -0.01 (-0.31%)

3.24

+0.25 (+8.36%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)08-15 2023-08-15
Inst Owners9.03%
Inst Owner Change191.35%
Ins Owners935.02%
Ins Owner Change0%
Market Cap104.06M
Analysts82.86
Price Target10.2 (214.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.39
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 2.84
EV/EBITDA N/A
EPS(TTM)-2.07
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.72
OCFYN/A
SpS2.34
BVpS2.79
TBVpS1.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.65%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y0.53%
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 6.08%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z -4.09
F-Score3
WACC7.88%
ROIC/WACCN/A
Cap/Depr(3y)24.29%
Cap/Depr(5y)15.49%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-419.17%
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)809.71%
Revenue growth 3Y119.26%
Revenue growth 5Y63.45%
Sales Q2Q%884.66%
Revenue Next Year34.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y54.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year62.08%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.72%
OCF growth 3YN/A
OCF growth 5YN/A